[Clinical experience with pimaricin ointment in the treatment of skin candidiasis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage*; D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010866:Natamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D009824:Ointments
D000935:Antifungal Agents; D009824:Ointments; D010866:Natamycin